Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer

Paul A. Bunn, Desmond N. Carney, Adi F. Gazdar, Jacqueline Whang-Peng, Mary J. Matthews

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Flow cytometric DNA content analysis, performed on clinical specimens from patients with lung cancer, was compared with clinical features, histological and/or cytological examination of the same specimen and, in some instances, to chromosome analysis and repeat DNA content analysis of short-term cultures. Tumors from 85% of non-small cell and 83% of small cell lung cancer patients had aneuploid DNA content; multiple aneuploid stem lines were present in 11% of patients. Comparisons with microscopic examination showed that aneuploid cells were detected in 122 of 167 clinical samples containing tumor cells and in 3 of 177 samples microscopically free of tumor. The high false-negative rate, shown to be due in large part to the presence of near-diploid tumor cells, makes single-parameter DNA analysis impractical for use in automated cytology. Short-term cultures of tumor cells, used to confirm that tumors had DNA content indistinguishable from diploid, demonstrated a single near-diploid peak on repeat DNA analysis with or without the addition of diploid lymphocytes and internal DNA standards. Chromosome banding studies showed clonal structural abnormalities with minimal numeric alterations. Survival of small cell lung cancer patients was similar for patients with near-diploid and aneuploid tumors. Cell cycle analysis could be performed in only a minority of samples, and there were no apparent differences in the proliferative fraction between lung cancer cell types. We conclude that flow cytometric DNA content analysis provides useful biological information and is a useful marker for following tumor cell cultures, but multiparameter analyses will be required for use in automated cytology and in cell kinetic studies.

Original languageEnglish
Pages (from-to)5026-5032
Number of pages7
JournalCancer Research
Volume43
Issue number10
Publication statusPublished - Oct 1 1983
Externally publishedYes

Fingerprint

Lung Neoplasms
Diploidy
DNA
Aneuploidy
Neoplasms
Small Cell Lung Carcinoma
Cell Biology
Cell Culture Techniques
Chromosome Banding
Tumor Biomarkers
Cell Cycle
Chromosomes
Lymphocytes
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bunn, P. A., Carney, D. N., Gazdar, A. F., Whang-Peng, J., & Matthews, M. J. (1983). Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer. Cancer Research, 43(10), 5026-5032.

Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer. / Bunn, Paul A.; Carney, Desmond N.; Gazdar, Adi F.; Whang-Peng, Jacqueline; Matthews, Mary J.

In: Cancer Research, Vol. 43, No. 10, 01.10.1983, p. 5026-5032.

Research output: Contribution to journalArticle

Bunn, PA, Carney, DN, Gazdar, AF, Whang-Peng, J & Matthews, MJ 1983, 'Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer', Cancer Research, vol. 43, no. 10, pp. 5026-5032.
Bunn, Paul A. ; Carney, Desmond N. ; Gazdar, Adi F. ; Whang-Peng, Jacqueline ; Matthews, Mary J. / Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer. In: Cancer Research. 1983 ; Vol. 43, No. 10. pp. 5026-5032.
@article{73543a39bf3e4c2fb1d7926ed5fc262f,
title = "Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer",
abstract = "Flow cytometric DNA content analysis, performed on clinical specimens from patients with lung cancer, was compared with clinical features, histological and/or cytological examination of the same specimen and, in some instances, to chromosome analysis and repeat DNA content analysis of short-term cultures. Tumors from 85{\%} of non-small cell and 83{\%} of small cell lung cancer patients had aneuploid DNA content; multiple aneuploid stem lines were present in 11{\%} of patients. Comparisons with microscopic examination showed that aneuploid cells were detected in 122 of 167 clinical samples containing tumor cells and in 3 of 177 samples microscopically free of tumor. The high false-negative rate, shown to be due in large part to the presence of near-diploid tumor cells, makes single-parameter DNA analysis impractical for use in automated cytology. Short-term cultures of tumor cells, used to confirm that tumors had DNA content indistinguishable from diploid, demonstrated a single near-diploid peak on repeat DNA analysis with or without the addition of diploid lymphocytes and internal DNA standards. Chromosome banding studies showed clonal structural abnormalities with minimal numeric alterations. Survival of small cell lung cancer patients was similar for patients with near-diploid and aneuploid tumors. Cell cycle analysis could be performed in only a minority of samples, and there were no apparent differences in the proliferative fraction between lung cancer cell types. We conclude that flow cytometric DNA content analysis provides useful biological information and is a useful marker for following tumor cell cultures, but multiparameter analyses will be required for use in automated cytology and in cell kinetic studies.",
author = "Bunn, {Paul A.} and Carney, {Desmond N.} and Gazdar, {Adi F.} and Jacqueline Whang-Peng and Matthews, {Mary J.}",
year = "1983",
month = "10",
day = "1",
language = "English",
volume = "43",
pages = "5026--5032",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Diagnostic and Biological Implications of Flow Cytometric DNA Content Analysis in Lung Cancer

AU - Bunn, Paul A.

AU - Carney, Desmond N.

AU - Gazdar, Adi F.

AU - Whang-Peng, Jacqueline

AU - Matthews, Mary J.

PY - 1983/10/1

Y1 - 1983/10/1

N2 - Flow cytometric DNA content analysis, performed on clinical specimens from patients with lung cancer, was compared with clinical features, histological and/or cytological examination of the same specimen and, in some instances, to chromosome analysis and repeat DNA content analysis of short-term cultures. Tumors from 85% of non-small cell and 83% of small cell lung cancer patients had aneuploid DNA content; multiple aneuploid stem lines were present in 11% of patients. Comparisons with microscopic examination showed that aneuploid cells were detected in 122 of 167 clinical samples containing tumor cells and in 3 of 177 samples microscopically free of tumor. The high false-negative rate, shown to be due in large part to the presence of near-diploid tumor cells, makes single-parameter DNA analysis impractical for use in automated cytology. Short-term cultures of tumor cells, used to confirm that tumors had DNA content indistinguishable from diploid, demonstrated a single near-diploid peak on repeat DNA analysis with or without the addition of diploid lymphocytes and internal DNA standards. Chromosome banding studies showed clonal structural abnormalities with minimal numeric alterations. Survival of small cell lung cancer patients was similar for patients with near-diploid and aneuploid tumors. Cell cycle analysis could be performed in only a minority of samples, and there were no apparent differences in the proliferative fraction between lung cancer cell types. We conclude that flow cytometric DNA content analysis provides useful biological information and is a useful marker for following tumor cell cultures, but multiparameter analyses will be required for use in automated cytology and in cell kinetic studies.

AB - Flow cytometric DNA content analysis, performed on clinical specimens from patients with lung cancer, was compared with clinical features, histological and/or cytological examination of the same specimen and, in some instances, to chromosome analysis and repeat DNA content analysis of short-term cultures. Tumors from 85% of non-small cell and 83% of small cell lung cancer patients had aneuploid DNA content; multiple aneuploid stem lines were present in 11% of patients. Comparisons with microscopic examination showed that aneuploid cells were detected in 122 of 167 clinical samples containing tumor cells and in 3 of 177 samples microscopically free of tumor. The high false-negative rate, shown to be due in large part to the presence of near-diploid tumor cells, makes single-parameter DNA analysis impractical for use in automated cytology. Short-term cultures of tumor cells, used to confirm that tumors had DNA content indistinguishable from diploid, demonstrated a single near-diploid peak on repeat DNA analysis with or without the addition of diploid lymphocytes and internal DNA standards. Chromosome banding studies showed clonal structural abnormalities with minimal numeric alterations. Survival of small cell lung cancer patients was similar for patients with near-diploid and aneuploid tumors. Cell cycle analysis could be performed in only a minority of samples, and there were no apparent differences in the proliferative fraction between lung cancer cell types. We conclude that flow cytometric DNA content analysis provides useful biological information and is a useful marker for following tumor cell cultures, but multiparameter analyses will be required for use in automated cytology and in cell kinetic studies.

UR - http://www.scopus.com/inward/record.url?scp=0020564634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020564634&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 5026

EP - 5032

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 10

ER -